Losartan reduced strokes and new-onset diabetes more than atenolol in essential hypertension

Blecker, David; Blecker, Saul B.
November 2002
ACP Journal Club;Nov/Dec2002, Vol. 137 Issue 3, p86
Academic Journal
Discusses research being done on the effectiveness of losartan-based therapy in reducing stroke and new-onset diabetes in hypertensive patients. Reference to study by R.B. Devereux and colleagues, published in the March 2002 issue of the journal 'Lancet'; Information on the study population; Intervention administered to the patients.


Related Articles

  • Losartan and the meaning of LIFE. Lip, G.Y.H. // Journal of Human Hypertension;May2002, Vol. 16 Issue 5, p289 

    Explores the treatment of hypertension with the use of losartan. Percentage reduction in the incidence of stroke; Reduction in cases of diabetes in patients treated with losartan; Mechanisms leading to the beneficial effects of losartan; Regression of left ventricular hypertrophy.

  • Community Surveillance of Stroke in Persons under 70 Years Old: Contribution of Uncontrolled Hypertension. Barker, William H.; Feldt, Karen S.; Feibel, John H. // American Journal of Public Health;Mar1983, Vol. 73 Issue 3, p260 

    Abstract: In 1979, a community-wide hospital surveillance system was established in Monroe County, New York (population 702,000), to investigate the continuing contribution of uncontrolled high blood pressure (HBP) to the occurrence o[ stroke. This paper reports findings among 200 consecutive...

  • Vascular health, diabetes, APOE and dementia: the Aging, Demographics, and Memory Study. Llewellyn, David J.; Lang, Iain A.; Matthews, Fiona E.; Plassman, Brenda L.; Rogers, Mary A. M.; Morgenstern, Lewis B.; Fisher, Gwenith G.; Kabeto, Mohammed U.; Langa, Kenneth M. // Alzheimer's Research & Therapy;2010, Vol. 2 Issue 3, p1 

    Introduction: Evidence from clinical samples and geographically limited population studies suggests that vascular health, diabetes and apolipoprotein ϵ4 (APOE) are associated with dementia. Methods: A population-based sample of 856 individuals aged 71 years or older from all contiguous...

  • Reducing the risk of stroke in type 2 diabetes: pathophysiological and therapeutic perspectives. Sander, Dirk; Kearney, Mark T. // Journal of Neurology;Oct2009, Vol. 256 Issue 10, p1603 

    Reducing the excess cerebrovascular burden in patients with type 2 diabetes remains a major therapeutic challenge, especially with respect to the high risk of recurrent events. Targeting the traditional metabolic risk factors of hypertension, dyslipidemia, and hyperglycemia has failed to remove...

  • Hypertension, Diabetes Are Clues. Dunbar, Mark T. // Review of Optometry;5/15/2010, Vol. 147 Issue 5, p93 

    The article discusses the effect of hypertension and diabetes which leads to the progressive vision loss of one's right eye. It mentions that macroaneurysm (MA) is commonly seen in older individuals and is more likely to be observed in females than in males. It cites some systemic risk factors...

  • High BP remains risk factor for diabetes patients.  // Drug Topics;10/6/2003 Supplement, Vol. 147 Issue 19, p4s 

    Reports on the results of a survey conducted by the American Diabetes Association on the risk of heart disease and stroke among diabetes patients with high blood pressure.

  • Untitled.  // Men's Fitness;Feb2005, Vol. 21 Issue 1, p33 

    Highlights a Northwestern University study which reported that regular workouts may help reduce risk for heart diseases, high blood pressure, stroke and diabetes.

  • New Perspectives on the Pharmacotherapy of Ischemic Stroke. Bradberry, J. Chris; Fagan, Susan C.; Gray, David R.; Moon, Yong S. K. // Journal of the American Pharmacists Association: JAPhA;Mar/Apr2004 Supplement 1, Vol. 44, pS46 

    Objective: To provide an overview of the impact of ischemic stroke and the steps that can be taken to reduce its burden through greater awareness of the disease, improved diagnosis and better treatment, with emphasis on the use of antiplatelet agents. Data Sources: Recent (1995-2003) published...

  • Perindopril and candesartan comparative efficacy and safety in type II diabetic hypertensive patients. Derosa, G; Cicero, A F G; Mugellini, A; Ciccarelli, L; Fogari, R // Journal of Human Hypertension;Jun2003, Vol. 17 Issue 6, p433 

    Cardiovascular and cerebrovascular disease risks are almost doubled when the hypertensive patient is also affected by diabetes mellitus. Lowering of blood pressure markedly decreases the rate of cardiovascular events and renal deterioration in these patients. The aim of this study is to compare...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics